ProQR Therapeutics (PRQR) Capital Expenditures (QoQ) (2013 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 687.79% |
| Sep 30, 2022 | -0.63% |
| Jun 30, 2022 | 9.99% |
| Mar 31, 2022 | -6.39% |
| Dec 31, 2021 | -24.72% |
| Sep 30, 2021 | -229.56% |
| Jun 30, 2021 | -62.24% |
| Mar 31, 2021 | 72.56% |
| Dec 31, 2020 | 54.38% |
| Sep 30, 2020 | 18.61% |
| Jun 30, 2020 | -173,247.25% |
| Mar 31, 2020 | 99.92% |
| Dec 31, 2019 | -642.95% |
| Sep 30, 2019 | 63.15% |
| Jun 30, 2019 | 61.88% |
| Mar 31, 2019 | -822,376.07% |
| Dec 31, 2018 | 99.97% |
| Sep 30, 2018 | 46.99% |
| Jun 30, 2018 | -4,420,146.52% |
| Mar 31, 2018 | -58.26% |
| Dec 31, 2017 | -44.33% |
| Sep 30, 2017 | 100.04% |
| Jun 30, 2017 | -110,184.95% |
| Mar 31, 2017 | -100.00% |
| Dec 31, 2016 | 582,677.45% |
| Dec 31, 2015 | 2,282,669.82% |
| Mar 31, 2015 | 14.34% |
| Dec 31, 2014 | -40.97% |
| Mar 31, 2014 | -229.80% |
| Dec 31, 2013 | 172.69% |